Adarsh Kumar Chiranjivi

Statistics

Publications

Citations

227

H-Index

Active since

2018

Affiliations

Translational Health Science and Technology Institute(Current)

All India Institute of Medical Sciences

Indian Institute of Technology Guwahati

Adarsh Kumar Chiranjivi is an author at Translational Health Science and Technology Institute specializing in life sciences, immunology, and molecular virology.

ORCID

Publications per year

2018–2022

Publications

Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania

Anupriya Baranwal, Adarsh Kumar Chiranjivi, Ashutosh Kumar et al. · Scientific Reports · 2018 · 71 citations · Full text

Life Sciences, Biotechnology, Materials Science +15

Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library

Hilal Ahmad Parray, Adarsh Kumar Chiranjivi, Shailendra Asthana et al. · Journal of Biological Chemistry · 2020 · 58 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro

Preeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi et al. · Frontiers in Immunology · 2021 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus

Praveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava et al. · International Immunopharmacology · 2021 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Antioxidant, anti-tyrosinase and anti-inflammatory activities of 3,5-dihydroxy-4′,7-dimethoxyflavone isolated from the leaves of Alpinia nigra

Manish Gupta, Sanjana Senthilkumar, Adarsh Kumar Chiranjivi et al. · Phytomedicine Plus · 2021 · 18 citations · Full text

Life Sciences, Botany, Pharmacology +17

1–5 of 8